Romosozumab Clinical Trials
7 recruitingDrug
Phase 44Phase 32
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
Osteogenesis Imperfecta
Amgen106 enrolled65 locationsNCT05972551
Recruiting
Phase 3
Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
FHA (Functional Hypothalamic Amenorrhea)
Massachusetts General Hospital114 enrolled2 locationsNCT06533865
Recruiting
Phase 4
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Osteoporosis
National Taiwan University Hospital90 enrolled1 locationNCT07283887
Recruiting
Sequential Therapies After Osteoanabolic Treatment
Osteoporosis, Postmenopausal
424 General Military Hospital150 enrolled8 locationsNCT06164795
Recruiting
Phase 4
Combined Anabolic Therapy
OsteoporosisOsteoporosis, Postmenopausal
Massachusetts General Hospital50 enrolled1 locationNCT06558188
Recruiting
Phase 4
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050
Recruiting
Phase 4
The Optimised Use of Romozosumab Study
Osteoporosis
University of Aarhus270 enrolled1 locationNCT06059222